mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
0.0098 |
0.8 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.8 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |